Electrolyte Disturbances in Critically Ill Cancer Patients: An Endocrine Perspective

Area of Science:

• Critical care medicine
• Oncology
• Nephrology

Background:

• Electrolyte disturbances are common in critically ill cancer patients.
• Hyponatremia, hypernatremia, hypocalcemia, and hypercalcemia are frequent abnormalities.
• Management in the ICU focuses on rapid evaluation and treatment to avoid complications.

Purpose of the Study:

• To review current evidence on evaluating and managing dysnatremias, hypocalcemia, and hypercalcemia in critically ill oncology patients.
• To discuss the role of emerging therapies in managing these electrolyte disorders.

Main Methods:

• A PubMed search was conducted to find relevant literature.
• Literature review focused on the evaluation and management of specific electrolyte abnormalities.
• The review included current evidence and new therapeutic options.

Main Results:

• Common electrolyte abnormalities in critically ill cancer patients include hyponatremia, hypernatremia, hypocalcemia, and hypercalcemia.
• Management strategies emphasize timely diagnosis and intervention.
• Newer treatments like vaptans, teriparatide, and denosumab show promise.

Conclusions:

• Early diagnosis and effective management of electrolyte disturbances are crucial for improving outcomes in critically ill cancer patients.
• Understanding and applying evidence-based guidelines, including novel therapies, is essential for optimal patient care.